‘There is no way to stop this’: ‘Biotech Barbie’ Cathy Tie on her mission to genetically modify babies
By Jenny Kleeman,
The Guardian
| 05. 30. 2026
The Canadian entrepreneur has always pushed the boundaries of gene editing, once attempting to turn horses into unicorns. Now she is set on modifying human embryos – something her controversial ex-husband was jailed for doing.
On a Friday evening in late April, Cathy Tie, the Canadian serial entrepreneur and self-styled “Biotech Barbie”, is centre stage at New York City’s famous Carnegie Hall, performing Saint-Saens’ Piano Concerto No 2 on a gleaming Steinway grand piano, accompanied by an orchestra. Her floor-length pink tulle gown shimmers with gold sequins; her dark hair cascades in waves over her caped shoulders. The music is passionate, but Tie’s expression is impassive. Her eyes dart between the piano keys and the sheet music in a flurry of concentration, but the rest of her face is totally still. She isn’t lost in the music; she’s focused on the job.
After the last notes ring out, Tie stands up and breaks into a tight smile and a brief bow before walking off stage, only to immediately return to receive the slightly awkward Happy Birthday sung by everyone in the orchestra and auditorium. This is Tie’s 30th birthday party. She has hired Carnegie Hall to mark the occasion. And, as I discover at the cocktail afterparty, most of the people invited to this performance...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 09.29.2026
Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...
Artificial Intelligence (AI) has been a major focus of news recently, as it should have been, under the appropriately ridiculous name of Hugging Face, “a leading collaboration platform and community hub for machine learning, artificial intelligence, and data science.” In July, Hugging Face was hacked. The platform itself responded:
Earlier this week, we detected and responded to an intrusion into part of our production infrastructure. This one was different from anything we had handled before in one important way...
By Miryam Naddaf, Nature | 09.21.2026
A wave of epigenetic therapies is offering hope as ways to cure chronic hepatitis B — a lingering liver infection that is caused by the hepatitis B virus (HBV) and affects more than 250 million people around the world. Currently...
By Karen Weintraub, Endpoints News | 09.16.2026
To better understand certain neuropsychiatric disorders, researchers at Stanford University have bred rodents that lack a cortex and hippocampus and then replaced those missing brain cells with human ones.
The altered mice, a scientific first, provided insights that would not...